Frederick G Vogt is Interim CEO & General Counsel of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 349,646 shares of IOVA, which is worth approximately $1.07 Million. The most recent transaction as insider was on Apr 14, 2023, when has been sold 20,834 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 350K
58.13% 3M change
147.39% 12M change
Total Value Held $1.07 Million

Frederick G Vogt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 14 2023
BUY
Exercise of conversion of derivative security
-
20,834 Added 23.01%
69,718 Common Stock
Jan 17 2023
SELL
Payment of exercise price or tax liability
$234,315 $6.43 p/Share
36,441 Reduced 42.71%
48,884 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
-
83,325 Added 49.41%
85,325 Common Stock
Nov 28 2022
BUY
Open market or private purchase
$5,980 $5.98 p/Share
1,000 Added 33.33%
2,000 Common Stock
Jun 01 2022
BUY
Open market or private purchase
$6,440 $6.44 p/Share
1,000 Added 50.0%
1,000 Common Stock
FGV

Frederick G Vogt

Interim CEO & General Counsel
San Carlos, CA

Track Institutional and Insider Activities on IOVA

Follow IOVANCE BIOTHERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA